Article Information
History
- March 14, 2022.
Article Versions
- Version 1 (January 23, 2022 - 13:51).
- Version 2 (February 22, 2022 - 08:18).
- Version 3 (March 6, 2022 - 11:49).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Glen H. Murata, MD*,#,
- Allison E. Murata, MSIM^,
- Douglas J. Perkins, PhD#,
- Heather M. Campbell, PharmD, PhD^&,
- Jenny T. Mao, MD, FCCP*,#,
- Brent Wagner, MD*,#,
- Benjamin H. Mcmahon, PhD% and
- Curt H. Hagedorn, MD*,#
- *New Mexico VA Health Care System, Albuquerque NM
- ^VA Cooperative Studies Program - Clinical Research Pharmacy Coordinating Center, Albuquerque NM
- #University of New Mexico School of Medicine, Albuquerque NM
- &University of New Mexico College of Pharmacy, Albuquerque NM
- %Los Alamos National Laboratory, Los Alamos NM
- ↵# Corresponding author; email: glen.murata{at}va.gov
Posted March 14, 2022.
SUSTAINED BENEFICIAL EFFECTS OF VACCINATION ON THE CASE FATALITY RATE FOR COVID-19 INFECTIONS
